Michael W. McCormick - 21 Feb 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Feb 2023, 18:32:10 UTC
Prior SEC filing
29 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael McCormick

Key filing fact

Michael W. McCormick filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 23 Feb 2023.

Key facts

  • This page summarizes Michael W. McCormick's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 23 Feb 2023, 18:32.

Change

  • Previous filing in this sequence was filed on 29 Jul 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CATX transaction Derivative

Stock Options (right to buy)

Award

Transaction value
$0
Shares
+470,000
Change %
+111%
Price
$0.000000
Shares after
894,615
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
470,000
Exercise price
$0.3800
Footnotes
F1
CATX transaction Derivative

Stock Options (right to buy)

Award

Transaction value
$0
Shares
+230,000
Change %
+26%
Price
$0.000000
Shares after
1,124,615
Date
21 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
230,000
Exercise price
$0.3800
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Vest monthly over three years.

Footnote F2

100% vests 2/21/2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .